Compare companies
Selected: 2 of 5
Key figures side by side
| Measure | Ucb Pharma AS2025 | Karl Storz Endoskopi Norge AS2025 |
|---|---|---|
| Sector and size | Handel · Medium | Handel · Medium |
| Score | 46 rank 13,223 of 22,952 | 46 rank 13,229 of 22,952 |
| Operating revenue | 263 MNOKmedian 93 MNOK | 61 MNOKmedian 93 MNOK |
| Operating margin | 3.3%median 3.0% | 5.2%median 3.0% |
| Profit margin | 1.9%median 2.8% | 4.0%median 2.8% |
| Return on assets | 6.0%median 11.6% | 13.0%median 11.6% |
| Equity ratio | 24.8%median 30.0% | 16.7%median 30.0% |
| Debt-to-equity | 3.04median 2.24 | 4.99median 2.24 |
| Current ratio | 1.33median 1.39 | 1.50median 1.39 |
| Revenue growth | 5.9%median 6.1% | 0.1%median 6.1% |
| Employees (Enhetsregisteret) | 5 | 12 |
The median is each company's own comparison group: same sector, financial year and size group. Source: Brønnøysund Register Centre.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
